The leading causes of death and disability worldwide are diseases connected to diabetes and cardiovascular conditions. Many drugs have been on the market for decades, but most nations, health care systems, and most crucially, people, have not been able to control these diseases to the extent that they should.
In 2010, like-minded experts from the healthcare, pharmaceutical, and business sectors came together to form Althera with the goal of improving patient care. Our goal is to provide patients with novel, reasonably priced oral drugs that are beneficial.
In the past 10 years, we have developed and invested in innovative, proprietary, patented technologies that have resulted in the creation of highly effective medications that are both inexpensive and easy to use, with the purpose of helping a large number of people achieve their health goals.